Results 201 to 210 of about 29,988 (285)

Dietary Index for Gut Microbiota and Leisure Time Physical Activity: The Potential Combined Protective Impact on Hypertension Risk

Food Science &Nutrition, Volume 13, Issue 12, December 2025.
Joint associations of dietary index for gut microbiota and leisure‐time physical activity with hypertension risk in U.S. adults. ABSTRACT Emerging evidence highlights the gut microbiome's role in hypertension via microbial metabolites and endothelial dysfunction, while the Dietary Index for Gut Microbiota (DI‐GM) quantifies diet quality for microbiota ...
Jiaxin Wang, Xinyi Lu, Yongting Zhao, Zewei Jiang, Jinghao Wang, Zhiguo Wang, Xiaofang Zhang   +6 more
wiley   +1 more source

Efficacy and safety of fecal microbiota transplantation in the management of parkinson's disease: a systematic review. [PDF]

BMC Neurol
Nabil Y, Helal MM, Qutob IA, Dawoud AIA, Allam S, Haddad R, Manasrah GM, AlEdani EM, Sleibi W, Faris A, Hassan AK, Nandwana V.   +11 more
europepmc   +1 more source

A Randomized Controlled Trial of Fecal Microbiota Transplantation for Parkinson’s Disease: Getting it right, if not PARFECT

Milan Beckers, Bryan Coburn, Lorraine V. Kalia, Bastiaan R. Bloem   +3 more
openalex   +2 more sources

Biosynthesis and Application of Catechins and Their Derivatives in Camellia sinensis

Food Science &Nutrition, Volume 13, Issue 12, December 2025.
This review summarizes the biosynthesis, structural diversity, and functional properties of catechins in tea. It highlights their tissue‐specific accumulation in different tea tissues and discusses the potential applications of catechin derivatives in functional foods and health‐related products.
Haiyi Yao, Yuxin Gu, Dibin Zhu, Dandan Tang, Wei Chen, Yongxian Chen, Jiaojiao Zhang, Liqiang Tan   +7 more
wiley   +1 more source

Maternal Fecal Microbiota Transplantation Mitigates Hypertension in Offspring Exposed to a High-Fructose Diet. [PDF]

Antioxidants (Basel)
Hsu CN, Hou CY, Tzeng HT, Wu KLH, Lee WC, Chang-Chien GP, Lin SF, Tain YL.   +7 more
europepmc   +1 more source

Dysbiosis and Therapeutic Modulation of the Gut Microbiota in Multiple Sclerosis: A Narrative Review

Health Science Reports, Volume 8, Issue 12, December 2025.
ABSTRACT Background and Aims Multiple sclerosis (MS) is a persistent autoimmune disease that affects the central nervous system. The etiology of MS is complex, involving a variety of genetic and environmental factors. Mounting evidence suggests that dysbiosis significantly impacts the progression of MS mainly through its direct effects upon the immune ...
Mojtaba Memariani, Hamed Memariani
wiley   +1 more source

Efficacy and safety of fecal microbiota transplantation for ulcerative colitis: protocol for an umbrella review of systematic reviews. [PDF]

Syst Rev
Huang J, Tang J, Wang Z, Zhang H, Wang F, Tang X, Zhou X.   +6 more
europepmc   +1 more source

MOMMY study profile: An integrative early‐life multi‐omics cohort in China

iMetaOmics, Volume 2, Issue 4, December 2025.
MOMMY cohort (The MOther‐infant Microbiota transmission and its link to long terM health of babY) is a large, prospective birth cohort uniquely designed to investigate maternal‐paternal‐infant microbiota transmission and its impact on child health within the understudied Chinese population.
Lin Zhang, Yingzhi Liu, Shilan Wang, Jessica Yuet‐Ling Ching, Wing Hung Tam, Ting Fan Leung, Tak Yeung Leung, Paul K. S. Chan, Joyce W. Y. Mak, Chun Pan Cheung, Hein Min Tun, Eugene B. Chang, Orlando DeLeon, Qitao Huang, Xiaoqian Chen, Huiyi Huo, Yinglei Miao, Pui Kuan Cheong, Ka Long Ip, Yuk Ling Yeung, Mei Kam Chang, Chunmei Lyu, Hongju Yang, Bona Li, Yushuo Fan, Yang Sun, Suhua Jiang, Siew Chien Ng, Francis Ka Leung Chan   +28 more
wiley   +1 more source

Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference. [PDF]

Inflamm Bowel Dis
Lopetuso LR, Deleu S, Puca P, Abreu MT, Armuzzi A, Barbara G, Caprioli F, Chieng S, Costello SP, Damiani A, Danese S, Del Chierico F, D'Haens G, Dotan I, Facciotti F, Falony G, Fantini MC, Fiorino G, Gionchetti P, Godny L, Hart A, Kupčinskas J, Iqbal T, Laterza L, Lombardini L, Maharshak N, Marasco G, Masucci L, Papa A, Paramsothy S, Petito V, Piovani D, Pugliese D, Putignani L, Raes J, Ribaldone DG, Sanguinetti M, Savarino EV, Sokol H, Vetrano S, Ianiro G, Cammarota G, Cominelli F, Pizarro TT, Tilg H, Gasbarrini A, Vermeire S, Scaldaferri F.   +47 more
europepmc   +1 more source

Extracellular Vesicles in Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities

iNew Medicine, Volume 1, Issue 1, December 2025.
The role of extracellular vesicles (EVs) in the progression of nonalcoholic fatty liver disease (NAFLD). Donor cells release EVs containing various molecules such as cholesterol, ceramide, sphingomyelin, miRNA, DNA, proteins, and lipids. These EVs are taken up by multiple recipient cells including Kupffer cells, adipocytes, β cells, adipose tissue ...
Yunsheng Dong, Lei Xiong, Nina Zhu, Zihan Wang, Hanqi Xia, Chen Cheng, Jianshang Huang, Yiran Han, Abduxukur Rahman, Junhao Zhao, Chonggui Jiang, Li Zuo, Hua Wang   +12 more
wiley   +1 more source